p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR

The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the presence of poly-PR/GR dipeptide repeats, which are encoded by the chromosome 9 open reading frame 72 (C9orf72) gene. Recently, it was shown that poly-PR/GR alters chromatin accessibility, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sinem Usluer, Emil Spreitzer, Benjamin Bourgeois, Tobias Madl
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
p53
Acceso en línea:https://doaj.org/article/965c28834c58400c9c7371f54ff27797
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:965c28834c58400c9c7371f54ff27797
record_format dspace
spelling oai:doaj.org-article:965c28834c58400c9c7371f54ff277972021-11-11T16:53:58Zp53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR10.3390/ijms2221114311422-00671661-6596https://doaj.org/article/965c28834c58400c9c7371f54ff277972021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11431https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the presence of poly-PR/GR dipeptide repeats, which are encoded by the chromosome 9 open reading frame 72 (C9orf72) gene. Recently, it was shown that poly-PR/GR alters chromatin accessibility, which results in the stabilization and enhancement of transcriptional activity of the tumor suppressor p53 in several neurodegenerative disease models. A reduction in p53 protein levels protects against poly-PR and partially against poly-GR neurotoxicity in cells. Moreover, in model organisms, a reduction of p53 protein levels protects against neurotoxicity of poly-PR. Here, we aimed to study the detailed molecular mechanisms of how p53 contributes to poly-PR/GR-mediated neurodegeneration. Using a combination of biophysical techniques such as nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization, turbidity assays, and differential interference contrast (DIC) microscopy, we found that p53 physically interacts with poly-PR/GR and triggers liquid–liquid phase separation of p53. We identified the p53 transactivation domain 2 (TAD2) as the main binding site for PR25/GR25 and showed that binding of poly-PR/GR to p53 is mediated by a network of electrostatic and/or hydrophobic interactions. Our findings might help to understand the mechanistic role of p53 in poly-PR/GR-associated neurodegeneration.Sinem UsluerEmil SpreitzerBenjamin BourgeoisTobias MadlMDPI AGarticlepoly-PR/GRneurodegenerative diseaseLLPSp53intrinsically disordered domainsmembraneless organellesBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11431, p 11431 (2021)
institution DOAJ
collection DOAJ
language EN
topic poly-PR/GR
neurodegenerative disease
LLPS
p53
intrinsically disordered domains
membraneless organelles
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle poly-PR/GR
neurodegenerative disease
LLPS
p53
intrinsically disordered domains
membraneless organelles
Biology (General)
QH301-705.5
Chemistry
QD1-999
Sinem Usluer
Emil Spreitzer
Benjamin Bourgeois
Tobias Madl
p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
description The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the presence of poly-PR/GR dipeptide repeats, which are encoded by the chromosome 9 open reading frame 72 (C9orf72) gene. Recently, it was shown that poly-PR/GR alters chromatin accessibility, which results in the stabilization and enhancement of transcriptional activity of the tumor suppressor p53 in several neurodegenerative disease models. A reduction in p53 protein levels protects against poly-PR and partially against poly-GR neurotoxicity in cells. Moreover, in model organisms, a reduction of p53 protein levels protects against neurotoxicity of poly-PR. Here, we aimed to study the detailed molecular mechanisms of how p53 contributes to poly-PR/GR-mediated neurodegeneration. Using a combination of biophysical techniques such as nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization, turbidity assays, and differential interference contrast (DIC) microscopy, we found that p53 physically interacts with poly-PR/GR and triggers liquid–liquid phase separation of p53. We identified the p53 transactivation domain 2 (TAD2) as the main binding site for PR25/GR25 and showed that binding of poly-PR/GR to p53 is mediated by a network of electrostatic and/or hydrophobic interactions. Our findings might help to understand the mechanistic role of p53 in poly-PR/GR-associated neurodegeneration.
format article
author Sinem Usluer
Emil Spreitzer
Benjamin Bourgeois
Tobias Madl
author_facet Sinem Usluer
Emil Spreitzer
Benjamin Bourgeois
Tobias Madl
author_sort Sinem Usluer
title p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
title_short p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
title_full p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
title_fullStr p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
title_full_unstemmed p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
title_sort p53 transactivation domain mediates binding and phase separation with poly-pr/gr
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/965c28834c58400c9c7371f54ff27797
work_keys_str_mv AT sinemusluer p53transactivationdomainmediatesbindingandphaseseparationwithpolyprgr
AT emilspreitzer p53transactivationdomainmediatesbindingandphaseseparationwithpolyprgr
AT benjaminbourgeois p53transactivationdomainmediatesbindingandphaseseparationwithpolyprgr
AT tobiasmadl p53transactivationdomainmediatesbindingandphaseseparationwithpolyprgr
_version_ 1718432190208933888